Revolutionizing Wellness: The Mental Health Impact of GLP-1s and Weight Loss

  • Webinar
  • GLP-1s
Attend

While a growing number of organizations recognize the critical need to address the rising prevalence of both stress and weight-related diseases among their populations, most programs still separate the treatment of mental and physical health. However, a recent study conducted by Noom highlights the advantages of a more integrated approach—one that can also advance mental wellness support for those taking GLP-1s.

Consider this: Each day, an estimated one million working Americans miss work due to stress-related issues, imposing substantial costs on businesses. This has far-reaching implications, as chronic stress can also heighten the risk of obesity and other chronic conditions such as Type 2 diabetes and cardiovascular disease.

Watch Noom’s Chief Medical Officer, Dr. Adonis Saremi, Clinical Solutions Consultant, Jennifer Jones, and Head of Healthcare Marketing, Kyle Smith, as they dive into the mental health impact of GLP-1s and weight loss, including:

  • The effects that GLP-1s and other weight loss medications can have on mental wellness
  • Valuable insights about the health and cost advantages of integrated employee wellness programs, including those for individuals taking GLP-1s
  • Insights from a recent study suggesting that solutions like Noom for Work and Noom for Health Systems can help people not only lose weight, but also cultivate behaviors that lead to healthier outcomes across multiple aspects of their lives

*Zippia, “40+ Worrisome Workplace Stress Statistics [2023]: Facts, Causes, and Trends,” Zippia.com, Feb. 11, 2023, https://www.zippia.com/advice/workplace-stress-statistics.

Speakers

  • Dr Adonis Saremi, MD

    Chief Medical Officer

  • Jennifer Jones

    Clinical Solutions Director Noom

  • Kyle Smith

    Head of Healthcare Marketing

Watch On-Demand Webinar

By submitting this form, I understand that Noom will process my personal information in accordance with their Privacy Policy.

Related Content

  • Blog
  • June 26
  • 1 min read

From Weight Loss to Risk: Understanding GLP-1’s Impact on Eating Disorders

Weight loss medication abuse is not new. Diet pills, caffeine, laxatives, and others have been around for a long time, but with the emergence of GLP-1s, more reports of disordered eating have surfaced. While these drugs have helped millions of individuals reach their weight loss goals, many suffer side effects that ultimately lead them to discontinue use, resulting not only in money lost, but weight regain. In this post, we'll deep dive into the discussion around GLP-1s and eating disorders, to ensure that employers, providers and health plans have access to the right support for members on GLP-1s.

By Noom Team
  • Blog
  • GLP-1s
  • June 26
  • 1 min read

Employer Strategies for Maximizing the Promise of GLP-1s

The numbers are clear: 160 million adults in the U.S. want to improve their health and well-being through weight loss. As many employers already know, adding obesity management programs to health benefit plans can boost employee motivation and health outcomes. For those who are affected, reducing weight by just 5-10% can improve risk factors and […]

By Noom Team
  • Blog
  • Noom Weight
  • June 26
  • 1 min read

Noom Weight Loss Study: Promising Results Among Breast Cancer Survivors

Post-diagnosis weight gain is common in early-stage breast cancer and is associated with increased risk of recurrence and mortality. Intentional weight loss is difficult to maintain, and digital lifestyle interventions may provide a scalable approach to address this challenge. Navigating the path to better health can be challenging, but with the right tools and support, […]

By Noom Team

Bring Noom to
your organization

Give your workforce a preview of what’s possible
for their physical and mental health.

REQUEST DEMO